Feasibility of dose reduction for [18F]FDG-PET/MR imaging of patients with non-lesional epilepsy
Nuklearmedizin - NuclearMedicine · 01.06.2023 · 62 (03) · 200-213
DOI: 10.1055/a-2015-7785 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nuklearmedizin - NuclearMedicine, erschienen am 01.06.2023. Verfasst von Hunor Kertész und 6 weiteren Autor:innen. Beteiligte Einrichtung: QIMP Team, Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Fluorodeoxyglucose F18, Epilepsy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
The aim of the study was to evaluate the effect of reduced injected [18F]FDG activity levels on the quantitative and diagnostic accuracy of PET images of patients with non-lesional epilepsy (NLE). Nine healthy volunteers and nine patients with NLE underwent 60-min dynamic list-mode (LM) scans on a fully-integrated PET/MRI system. Injected FDG activity levels were reduced virtually by randomly removing counts from the last 10-min of the LM data, so as to simulate the following activity levels: 50 %, 35 %, 20 %, and 10 % of the original activity. Four image reconstructions were evaluated: standard OSEM, OSEM with resolution recovery (PSF), the A-MAP, and the Asymmetrical Bowsher (AsymBowsher) algorithms. For the A-MAP algorithms, two weights were selected (low and high). Image contrast and noise levels were evaluated for all subjects while the lesion-to-background ratio (L/B) was only evaluated for patients. Patient images were scored by a Nuclear Medicine physician on a 5-point scale to assess clinical impression associated with the various reconstruction algorithms. The image contrast and L/B ratio characterizing all four reconstruction algorithms were similar, except for reconstructions based on only 10 % of total counts. Based on clinical impression, images with diagnostic quality can be achieved with as low as 35 % of the standard injected activity. The selection of algorithms utilizing an anatomical prior did not provide a significant advantage for clinical readings, despite a small improvement in L/B (< 5 %) using the A-MAP and AsymBowsher reconstruction algorithms. In patients with NLE who are undergoing [18F]FDG-PET/MR imaging, the injected [18F]FDG activity can be reduced to 35 % of the original dose levels without compromising.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- QIMP Team, Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria.
- Division of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.
- Ion Beam Applications, Protontherapy Center Quironsalud, Madrid, Spain.
- Department of Radiology, Wayne State University School of Medicine, The Detroit Medical Center, Children's Hospital of Michigan, Detroit, United States.
Zitieren
APA
Kertész, H., Traub-Weidinger, T., Cal-Gonzalez, J., Rausch, I., Muzik, O., Shyiam Sundar, L. K., & Beyer, T. (2023). Feasibility of dose reduction for [18F]FDG-PET/MR imaging of patients with non-lesional epilepsy. Nuklearmedizin - NuclearMedicine, 62(03), 200-213. https://doi.org/10.1055/a-2015-7785
Vancouver
Kertész H, Traub-Weidinger T, Cal-Gonzalez J, Rausch I, Muzik O, Shyiam Sundar LK, et al. Feasibility of dose reduction for [18F]FDG-PET/MR imaging of patients with non-lesional epilepsy. Nuklearmedizin - NuclearMedicine. 2023;62(03):200-213. doi:10.1055/a-2015-7785
BibTeX
@article{Kertsz2023,
author = {Kertész, Hunor and Traub-Weidinger, Tatjana and Cal-Gonzalez, Jacobo and Rausch, Ivo and Muzik, Otto and Shyiam Sundar, Lalith Kumar and Beyer, Thomas},
title = {Feasibility of dose reduction for [18F]FDG-PET/MR imaging of patients with non-lesional epilepsy},
journal = {Nuklearmedizin - NuclearMedicine},
year = {2023},
volume = {62},
number = {03},
pages = {200--213},
doi = {10.1055/a-2015-7785}
}
EUVIMED